18 related articles for article (PubMed ID: 1965448)
1. Radiolabeling of an anti-carcinoembryonic antigen antibody Fab' fragment (CEA-Scan) with the positron-emitting radionuclide Tc-94m.
Griffiths GL; Goldenberg DM; Roesch F; Hansen HJ
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3001s-3003s. PubMed ID: 10541334
[TBL] [Abstract][Full Text] [Related]
2. Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids.
Sutherland R; Buchegger F; Schreyer M; Vacca A; Mach JP
Cancer Res; 1987 Mar; 47(6):1627-33. PubMed ID: 3545451
[TBL] [Abstract][Full Text] [Related]
3. Site-specific modifications of light chain glycosylated antilymphoma (LL2) and anti-carcinoembryonic antigen (hImmu-14-N) antibody divalent f1agments.
Govindan SV; Goldenberg DM; Griffiths GL; Leung SO; Losman MJ; Hansen HJ
Cancer Res; 1995 Dec; 55(23 Suppl):5721s-5725s. PubMed ID: 7493334
[TBL] [Abstract][Full Text] [Related]
4. Ablation of human colon carcinoma in nude mice by 131I-labeled monoclonal anti-carcinoembryonic antigen antibody F(ab')2 fragments.
Buchegger F; Pfister C; Fournier K; Prevel F; Schreyer M; Carrel S; Mach JP
J Clin Invest; 1989 May; 83(5):1449-56. PubMed ID: 2708519
[TBL] [Abstract][Full Text] [Related]
5. Radioiodination of murine anti-alpha-foetoprotein E.9 monoclonal antibody and its F(ab')2 fragment for the diagnosis of hepatocellular carcinoma.
Beyers M; Aspinall S; Conradie JD; Fourie PJ
Nuklearmedizin; 1988 Jun; 27(3):87-94. PubMed ID: 2457207
[TBL] [Abstract][Full Text] [Related]
6. Early clinical results with anti-CEA F(ab')2 fragments labelled with 99mTc.
Seccamani E; Bonino C; Tarditi L; Camagna M; Moscatelli G; Riva P
J Nucl Med Allied Sci; 1990; 34(4 Suppl):169-72. PubMed ID: 1965448
[No Abstract] [Full Text] [Related]
7. F(ab')2 fragments versus intact antibody--an isodose comparison.
Humm JL; Chin LM; Macklis RM
J Nucl Med; 1990 Jun; 31(6):1045-7. PubMed ID: 2189961
[No Abstract] [Full Text] [Related]
8. Labeling of anti-tumor antibodies and antibody fragments with Tc-99m.
Hansen HJ; Jones AL; Grebenau R; Kunz A; Goldenberg DM
Cancer Treat Res; 1990; 51():233-44. PubMed ID: 1977447
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
